Lung tumors & pleural lesions

Size: px
Start display at page:

Download "Lung tumors & pleural lesions"

Transcription

1 Lung tumors & pleural lesions

2 A brief introduction 95% of lung tumors are carcinomas Among the remaining 5%, we will discuss: -Hamartoma the most common benign lung tumor spherical, coin lesion on x-rays small (1-4cm) consists mainly of mature cartilage admixed with fat, fibrous tissue, and blood vessels in various proportions -Carcinoid a semi-benign/semi-malignant tumor considered as malignant

3 Carcinomas, overview The most common cause of cancer death in men & women Decreasing among men and increasing among women Peak incidence: 50s & 60s Prognosis is bad in general even if localized in the lung, the 5-year survival rate is near 45%

4 Lung cancer, 4 major histologic types 1- Small cell carcinoma 2- Adenocarcinoma 3- Squamous cell carcinoma 4- Large cell carcinoma others, some are mixed Previously: Small cell lung cancer (SCLC) aggressive, metastasis common since diagnosis with median survival of 1 year much mitotic and apoptotic activity, necrosis, crushing artifacts and Azzopardi effect always needs chemotherapy Previously: Non-small cell lung cancer (NSCLC) Note: Small cell carcinoma & carcinoid are both considered neuroendocrine tumors

5 Smoking The most common primary lung tumor in USA now is: Adenocarcinoma (replaced squamous cell carcinoma because smoking in comparison to the past) Small and squamous cell carcinomas have the strongest association with smoking but smoking is also a risk for adenocarcinoma Adenocarcinomas are the most common primary tumors arising in: -women -never-smokers -individuals younger than 45 years of age 90% of lung cancers occurs in smokers or who stopped recently Women are more susceptibile to carcinogens in tobacco smoke than men Cessation of smoking decreases the risk but never to baseline Also passive smokers, pipes, and cigars lesser risk

6 Molecular pathogenesis of lung cancer Abnormalities in tumor suppressors on the short arm of chromosome 3 an early event TP53 tumor suppressor gene mutations and KRAS oncogene mutations later Changes accumulate in smokers in a stepwise fashion and in large areas (field effect) forming a fertile soil for cancer to occur A subset of adenocarcinomas (10% in whites & 30% in Asians) harbor EGFR mutations a receptor tyrosine kinase (oncogene) targeted therapy KRAS is downstream of EGFR and their mutations are mutually exclusive (do not occur at the same time) Other tyrosine kinases that may be mutated in adenocarcinoma and can respond to their specific targeted therapies: ALK, ROS1, HER2, c-met the concept of personalized lung cancer therapy : molecular pathogenesis guides the treatment

7 Important event sequences Atypical adenomatous hyperplasia adenocarcinoma in situ invasive adenocarcinoma this is proposed for some adenocarcinomas Squamous metaplasia squamous dysplasia squamous cell carcinoma in situ invasive squamous cell carcinoma These precursor lesion may last for many years

8 Other environmental & occupational risk factors Uranium Asbestos (alone: 5-fold increased risk, with smoking: 55-fold) Chromium Arsenic Nickel Vinyl chloride

9 Morphology of lung cancer Adenocarcinoma peripherally more Squamous cell and small cell carcinomas centrally more (in major bronchi) Adenocarcinoma may be glandular (acinar), papillary, mucinous or solid Adenocarcinoma in situ previously called: bronchioalveolar carcinoma characteristic growth along preexisting alveolar septa, without invasion

10 TTF-1 (thyroid transcription factor 1) especially positive in lung Adenocarcinoma and small cell carcinoma Adenocarcinoma in situ Adenocarcinoma gland-forming

11 Squamous cell carcinoma, some notes Necrosis with cavitation is more common Metastasis outside thorax is slower than others Earlier precursor events can be detected as abnormal cells in cytopathologic examination of sputum or bronchoalveolar lavage Variable morphology (from well differentiated (much more keratin) to poorly differentiated)

12 Some clinical presentations Involvement of left supraclavicular lymph node = Virchow node Compression of superior vena cava with venous congestion of the face Vena caval syndrome Apical tumors if compressing sympathetic plexus Horner syndrome? these apical neoplasms are called: Pancoast tumors

13 Paraneoplastic syndromes of lung cancer In 3-10% of cases Mainly: 1-Hypercalcemia (parathyroid hormone-related peptide) squamous cell carcinoma 2-Cushing syndrome (ACTH) small cell carcinoma also carcinoid 3-SIADH (syndrome of inappropriate ADH secretion) small cell carcinoma 4-Neuromuscular syndromes small cell carcinoma 5-Clubbing of fingers and pulmonary osteoarthropathy 6-Coagulation abnormalities (migratory thrombophlebitis, DIC) 7-Carcinoid syndrome carcinoid tumor also small cell carcinoma

14 Carcinoid tumors Mainly intrabronchial growth, well-circumscribed The cells contain neurosecretory granules (features of neuroendocrine tumors) It is better to consider them as: low-grade neuroendocrine carcinomas (malignant) May rarely secrete hormonally active polypeptides carcinoid syndrome Classified as typical (indolent) and atypical (worse) Resectable and curable Young adults (mean 40 years) Sometimes as part of MEN syndrome 5-15% metastasize to hilar lymph nodes, but distal metastasis is rare

15 Carcinoid tumors, morphology Typical carcinoid: nests of uniform cells that have regular round nuclei with salt-and-pepper chromatin, absent or rare mitoses and little pleomorphism Atypical carcinoid: necrosis and more mitoses

16 Carcinoid tumors, clinical notes Symptoms related to bronchial location (cough, hemoptysis, obstruction & infection) Peripheral carcinoids are often asymptomatic and discovered incidentally Rarely: carcinoid syndrome (intermittent attacks of diarrhea, flushing and cyanosis) The reported 5- and 10-year survival rates for typical carcinoids are above 85%, while these rates drop to 56% and 35%, respectively, for atypical carcinoids

17 Metastases to the lung Any pattern of growth but remember that multiplicity is more with metastatic than primary (not always)

18 A brief note on malignant mesothelioma of the pleura A rare cancer of mesothelial cells, usually arising in the parietal or visceral pleura; it also occurs much less commonly in the peritoneum and pericardium 80% to 90% of individuals with this cancer have a history of exposure to asbestos (shipyard workers, miners, insulators) The latent period for developing malignant mesothelioma after the initial exposure is long, often 25 to 40 years The combination of cigarette smoking and asbestos exposure greatly increases the risk for developing lung carcinoma, but it does not increase the risk for developing malignant mesothelioma The lifetime risk after exposure does not diminish over time (unlike with smoking, in which the risk decreases after cessation) BAP1 mutations are common (a tumor suppressor gene important for DNA repair)

19 Pleural effusions Transudates or exudates transudate = hydrothorax The most common cause of bilateral hydrothorax is: Congestive heart failure An exudate, characterized by protein content greater than 30 g/l and, often, inflammatory cells, suggests pleuritis The four principal causes of pleural exudate formation are: infection (suppurative pleuritis or empyema)-cancer (commonly hemorrhagic)- pulmonary infarction-viral pleuritic others: connective tissue diseases and uremia

20 Pneumothorax Simple/spontaneous without known lung disease young healthy men Secondary with known thoracic or lung disorder

21 Other pleural fluid accumulations

22

Reparatory system 18 lectures Heyam Awad

Reparatory system 18 lectures Heyam Awad Reparatory system 18 lectures 8-10 Heyam Awad These lectures cover the following topics 1. Diffuse hemorrhagic syndromes 2. Lung tumors important: theses slides are your study source for these lectures.

More information

Reparatory system lectures Heyam Awad

Reparatory system lectures Heyam Awad Reparatory system lectures 8-10 Heyam Awad note These lectures cover the following topics 1. Diffuse hemorrhagic syndromes 2. Lung tumors important: theses slides are your study source for these lectures.

More information

Cancer in the United States, 2004

Cancer in the United States, 2004 Cancer in the United States, 2004 Five-year Cancer Survival Rates (%) US 1974-1998 100 90 80 70 60 50 40 30 20 10 0 1974-1976 1983-1985 1992-1998 Prostate Lung Colon Breast Source: CA Cancer J Clin 2000;50:7-33

More information

Lung Cancer Risks. Cancer in the United States, Cancer Death Rates, US The Scheme: From Nicotine Addiction to Lung Cancer

Lung Cancer Risks. Cancer in the United States, Cancer Death Rates, US The Scheme: From Nicotine Addiction to Lung Cancer Cancer in the United States, 2004 Lung Cancer Risks Cigarette Smoking Environmental Tobacco Smoke Other Carcinogens Asbestos, Arsenic, Radon, Bis(chloromethyl) ether, Chromium, Foundry fumes, nickel, mustard

More information

Pathology of Tumors of Lung Pathology of Tumors of Lung o Classify lung tumors.

Pathology of Tumors of Lung Pathology of Tumors of Lung o Classify lung tumors. Pathology of Tumors of Lung Pathology of Tumors of Lung o Classify lung tumors. o Classify bronchogenic carcinoma. o Discuss etiopathogenesis of bronchogenic ca. o Discuss morphological features of squamous

More information

Bronchogenic Carcinoma

Bronchogenic Carcinoma A 55-year-old construction worker has smoked 2 packs of ciggarettes daily for the past 25 years. He notes swelling in his upper extremity & face, along with dilated veins in this region. What is the most

More information

Respiratory Tract Cytology

Respiratory Tract Cytology Respiratory Tract Cytology 40 th European Congress of Cytology Liverpool, UK Momin T. Siddiqui M.D. Professor of Pathology and Laboratory Medicine Director of Cytopathology Emory University Hospital, Atlanta,

More information

Cancer in the United States, 2007

Cancer in the United States, 2007 Cancer in the United States, 2007 Lung Cancer in the United States Annual Cancer Deaths Five-Year Survival 100 90 80 70 60 50 40 30 20 10 0 1974-1976 1983-1985 1992-1998 Prostate Lung Colon Breast The

More information

Non Small Cell Lung Cancer Histopathology ד"ר יהודית זנדבנק

Non Small Cell Lung Cancer Histopathology דר יהודית זנדבנק Non Small Cell Lung Cancer Histopathology ד"ר יהודית זנדבנק 26.06.09 Lecture outlines WHO histological classification Macro/Micro assessment Early diagnosis Minimal pathology Main subtypes SCC, AdCa, LCLC

More information

Lung Tumors. Objectives: Editing File

Lung Tumors. Objectives: Editing File Lung Tumors Objectives: Know the epidemiology of lung cancer Is aware of classification of bronchogenic carcinoma which include: squamous carcinoma, adenocarcinoma, small cell and large cell (anaplastic)

More information

Cancer in the United States, Lung Cancer Risks. Cancer Death Rates, US The Scheme: From Nicotine Addiction to Lung Cancer

Cancer in the United States, Lung Cancer Risks. Cancer Death Rates, US The Scheme: From Nicotine Addiction to Lung Cancer Cancer in the United States, 2009 Lung Cancer Risks Cigarette Smoking Environmental Tobacco Smoke Other Carcinogens Asbestos, Arsenic, Radon, Bis(chloromethyl) ether, Chromium, Foundry fumes, nickel, mustard

More information

Cancer in the United States, 2009

Cancer in the United States, 2009 Cancer in the United States, 2009 Lung Cancer in the United States Annual Cancer Deaths 100 90 80 70 60 50 40 30 20 10 0 1974-1976 1983-1985 1992-1998 Prostate Lung Colon Breast 2/6/2007 1 The Scheme:

More information

Cancer in the United States, Jemal, A. et al. CA Cancer J Clin 2009;59:

Cancer in the United States, Jemal, A. et al. CA Cancer J Clin 2009;59: Cancer in the United States, 2009 Jemal, A. et al. CA Cancer J Clin 2009;59:225-249 Lung Cancer in the United States Annual Cancer Deaths The Scheme: From Nicotine Addiction to Lung Cancer Cigarette smoking

More information

3/30/2009 Lung Cancer Deaths 2008 Lung Cancer Deaths Lung Cancer Deaths--Males Males 5

3/30/2009 Lung Cancer Deaths 2008 Lung Cancer Deaths Lung Cancer Deaths--Males Males 5 LUNG CANCER 2009 Mark B. Stoopler, M.D. Division of Medical Oncology Very common Very lethal Lung Cancer Median age of diagnosis approximately 70 years, but affects all ages(even pediatric!) Advances in

More information

Lung Cancer Incidence 2008 Lung Cancer Deaths-Males 2008 Incidence Total U.S.(all types): 1,437,180 Lung Cancer Deaths-Females Lung cancer 215,000(15%

Lung Cancer Incidence 2008 Lung Cancer Deaths-Males 2008 Incidence Total U.S.(all types): 1,437,180 Lung Cancer Deaths-Females Lung cancer 215,000(15% Multidisciplinary approach 2009 Mark B. Stoopler, M.D. Division of Medical Oncology Neurology Neurosurgery Orthopedic surgery General surgery Vascular surgery Gastroenterology Cardiology Lung Cancer Very

More information

Histopathology of NSCLC, IHC markers and ptnm classification

Histopathology of NSCLC, IHC markers and ptnm classification ESMO Preceptorship on Non-Small Cell Lung Cancer November 15 th & 16 th 2017 Singapore Histopathology of NSCLC, IHC markers and ptnm classification Prof Keith M Kerr Department of Pathology, Aberdeen University

More information

Lung Neoplasia II Resection specimens Pathobasic. Lukas Bubendorf Pathology

Lung Neoplasia II Resection specimens Pathobasic. Lukas Bubendorf Pathology Lung Neoplasia II Resection specimens Pathobasic Lukas Bubendorf Pathology Agenda Preneoplastic lesions Histological subtypes of lung cancer Histological patterns of AC Cells of origin and characteristic

More information

Lung Cancer Very common Very lethal Median age of diagnosis i approximately 70 years, but affects all ages In the United States, the highest incidence

Lung Cancer Very common Very lethal Median age of diagnosis i approximately 70 years, but affects all ages In the United States, the highest incidence LUNG CANCER 2010 Mark B. Stoopler, M.D. Division of Medical Oncology Lung Cancer Very common Very lethal Median age of diagnosis i approximately 70 years, but affects all ages In the United States, the

More information

The Scheme: From Nicotine Addiction to Lung Cancer

The Scheme: From Nicotine Addiction to Lung Cancer 2007 Estimated US Cancer Cases* Prostate 29% Lung & bronchus 15% Colon & rectum 10% Urinary bladder 7% Non-Hodgkin 4% lymphoma Melanoma of skin 4% Kidney 4% Leukemia 3% Oral cavity 3% Pancreas 2% All Other

More information

Respiratory Pathology. Kristine Krafts, M.D.

Respiratory Pathology. Kristine Krafts, M.D. Respiratory Pathology Kristine Krafts, M.D. Normal lung: alveolar spaces Respiratory Pathology Outline Acute respiratory distress syndrome Obstructive lung diseases Restrictive lung diseases Vascular

More information

2007 Estimated US Cancer Cases* 2007 Estimated US Cancer Deaths*

2007 Estimated US Cancer Cases* 2007 Estimated US Cancer Deaths* 2007 Estimated US Cancer Cases* Prostate 29% Lung & bronchus 15% Colon & rectum 10% Urinary bladder 7% Non-Hodgkin 4% lymphoma Melanoma of skin 4% Kidney 4% Leukemia 3% Oral cavity 3% Pancreas 2% All Other

More information

Cytological Sub-classification of Lung Cancer: Morphologic and Molecular Characteristics. Mercè Jordà, University of Miami

Cytological Sub-classification of Lung Cancer: Morphologic and Molecular Characteristics. Mercè Jordà, University of Miami Cytological Sub-classification of Lung Cancer: Morphologic and Molecular Characteristics Mercè Jordà, University of Miami Mortality Lung cancer is the most frequent cause of cancer incidence and mortality

More information

Outline. The Lung Cancer Patient in 2011 Not the Marlboro Man. Lung Cancer

Outline. The Lung Cancer Patient in 2011 Not the Marlboro Man. Lung Cancer Outline The Lung Cancer Patient in 2011 Not the Marlboro Man Jeanne Griffin Vaughn, APN-BC, AOCN Epidemiology Staging and Patterns of Spread Clinical Presentation Treatments March 26, 2011 Lung Cancer

More information

Lung Cancer. Definition of lung cancer Malignancy arising from lung tissue

Lung Cancer. Definition of lung cancer Malignancy arising from lung tissue Lung Cancer Definition of lung cancer Malignancy arising from lung tissue Epidemiology of lung cancer Commonest malignancy in western world Commonest cause of death in men and women in the UK Approximately

More information

THYMIC CARCINOMAS AN UPDATE

THYMIC CARCINOMAS AN UPDATE THYMIC CARCINOMAS AN UPDATE Mark R. Wick, M.D. University of Virginia Medical Center Charlottesville, VA CARCINOMA OF THE THYMUS General Clinical Features No apparent gender predilection Age range of 35-75

More information

Lung diseases. Fatima Obeidat, MD Assistant Professor of Pathology/Neuropathology University of Jordan

Lung diseases. Fatima Obeidat, MD Assistant Professor of Pathology/Neuropathology University of Jordan Lung diseases Fatima Obeidat, MD Assistant Professor of Pathology/Neuropathology University of Jordan Restrictive lung disease Granulomatous types I. Sarcoidosis - Although sarcoidosis is an example of

More information

LUNG CANCER. pathology & molecular biology. Izidor Kern University Clinic Golnik, Slovenia

LUNG CANCER. pathology & molecular biology. Izidor Kern University Clinic Golnik, Slovenia LUNG CANCER pathology & molecular biology Izidor Kern University Clinic Golnik, Slovenia 1 Pathology and epidemiology Small biopsy & cytology SCLC 14% NSCC NOS 4% 70% 60% 50% 63% 62% 61% 62% 59% 54% 51%

More information

The International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements

The International Association for the Study of Lung Cancer (IASLC) Lung Cancer Staging Project, Data Elements Page 1 Contents 1.1. Registration... 2 1.2. Patient Characteristics... 3 1.3. Laboratory Values at Diagnosis... 5 1.4. Lung Cancers with Multiple Lesions... 6 1.5. Primary Tumour Description... 10 1.6.

More information

Molecular Pathobiology of Lung Cancer. William K. Funkhouser, MD PhD Department of Pathology and Lab Medicine University of North Carolina

Molecular Pathobiology of Lung Cancer. William K. Funkhouser, MD PhD Department of Pathology and Lab Medicine University of North Carolina Molecular Pathobiology of Lung Cancer William K. Funkhouser, MD PhD Department of Pathology and Lab Medicine University of North Carolina Outline Lung Anatomy Lung Carcinoma Classification & Morphology

More information

B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life.

B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life. B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life. b. Deficiency of dietary iodine: - Is linked with a

More information

Lung Cytology: Lessons Learned from Errors in Practice

Lung Cytology: Lessons Learned from Errors in Practice Lung Cytology: Lessons Learned from Errors in Practice Stephen S. Raab, M.D. Department of Laboratory Medicine Eastern Health and Memorial University of Newfoundland, St. John s, NL and University of Washington,

More information

Respiratory Interactive Session. Elaine Borg

Respiratory Interactive Session. Elaine Borg Respiratory Interactive Session Elaine Borg Case 1 Respiratory Cytology 55 year old gentleman Anterior mediastinal mass EBUS FNA Case 1 Respiratory Cytology 55 year old gentleman with anterior mediastinal

More information

Non-Small Cell Lung Cancer Causes, Risk Factors, and Prevention

Non-Small Cell Lung Cancer Causes, Risk Factors, and Prevention Non-Small Cell Lung Cancer Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors for

More information

Difficult Diagnoses and Controversial Entities in Neoplastic Lung

Difficult Diagnoses and Controversial Entities in Neoplastic Lung Difficult Diagnoses and Controversial Entities in Neoplastic Lung Lynette M. Sholl, M.D. Associate Pathologist, Brigham and Women s Hospital Chief, Pulmonary Pathology Service Associate Professor, Harvard

More information

8/22/2016. Major risk factors for the development of lung cancer are: Outline

8/22/2016. Major risk factors for the development of lung cancer are: Outline Carcinomas of the Lung: Changes in Staging, Adenocarcinoma Classification and Genetics Grace Y. Lin, M.D., Ph.D. Outline Background Staging of Lung Cancer: Review of the 2010 7 th Edition of the AJCC Cancer

More information

Small Cell Lung Cancer Causes, Risk Factors, and Prevention

Small Cell Lung Cancer Causes, Risk Factors, and Prevention Small Cell Lung Cancer Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors for small

More information

LUNG CANCER PATHOLOGY: UPDATE ON NEUROENDOCRINE LUNG TUMORS

LUNG CANCER PATHOLOGY: UPDATE ON NEUROENDOCRINE LUNG TUMORS LUNG CANCER PATHOLOGY: UPDATE ON NEUROENDOCRINE LUNG TUMORS William D. Travis, M.D. Attending Thoracic Pathologist Memorial Sloan Kettering Cancer Center New York, NY PULMONARY NE TUMORS CLASSIFICATION

More information

LUNG CANCER. Agnieszka Słowik, MD. Department of Oncology, University Hospital in Cracow Jagiellonian University

LUNG CANCER. Agnieszka Słowik, MD. Department of Oncology, University Hospital in Cracow Jagiellonian University LUNG CANCER Agnieszka Słowik, MD Department of Oncology, University Hospital in Cracow Jagiellonian University Epidemiology Most common malignancy worldwide Place of lung cancer among other malignancies

More information

Lung Cancer-a primer. Sai Yendamuri, MD Professor and Chair, Dept of Thoracic Surgery,RPCI,Buffalo

Lung Cancer-a primer. Sai Yendamuri, MD Professor and Chair, Dept of Thoracic Surgery,RPCI,Buffalo Lung Cancer-a primer Sai Yendamuri, MD Professor and Chair, Dept of Thoracic Surgery,RPCI,Buffalo CLINICAL CATEGORIES THE SOLITARY PULMONARY NODULE MULTIPLE PULMONARY NODULES Differential Diagnosis Malignant

More information

Fast Facts: Non-Small-Cell Lung Cancer

Fast Facts: Non-Small-Cell Lung Cancer Fast Facts Fast Facts: Non-Small-Cell Lung Cancer Mary O Brien MD FRCP Consultant Medical Oncologist The Royal Marsden NHS Foundation Trust London, UK Benjamin Besse MD PhD Thoracic Cancer Unit, Head Department

More information

YOUR LUNG CANCER PATHOLOGY REPORT

YOUR LUNG CANCER PATHOLOGY REPORT UNDERSTANDING SERIES YOUR LUNG CANCER PATHOLOGY REPORT 1-800-298-2436 LungCancerAlliance.org A GUIDE FOR THE PATIENT 1 CONTENTS What is a Pathology Report?...2 The Basics...3 Sections of a Pathology Report...6

More information

Problem 1: Differential of Neuroendocrine Carcinoma 3/23/2017. Disclosure of Relevant Financial Relationships

Problem 1: Differential of Neuroendocrine Carcinoma 3/23/2017. Disclosure of Relevant Financial Relationships Differential of Neuroendocrine Carcinoma Alain C. Borczuk,MD Weill Cornell Medicine Disclosure of Relevant Financial Relationships USCAP requires that all faculty in a position to influence or control

More information

Definition. Epidemiology. Lung Cancer is a disease which cancer (malignant tumors) cells grow in the lungs. LUNG CANCER Debra Mercer BSN, RN, RRT

Definition. Epidemiology. Lung Cancer is a disease which cancer (malignant tumors) cells grow in the lungs. LUNG CANCER Debra Mercer BSN, RN, RRT LUNG CANCER Debra Mercer BSN, RN, RRT Definition Lung Cancer is a disease which cancer (malignant tumors) cells grow in the lungs. Epidemiology Leading cancer killer in both men and women in the US - 169,

More information

Lecture Goals. Lung (Bronchogenic) Cancer. Causes of Lung Cancer. Elizabeth Weihe, MD Assistant Professor of Radiology Director of UCSD RECIST clinic

Lecture Goals. Lung (Bronchogenic) Cancer. Causes of Lung Cancer. Elizabeth Weihe, MD Assistant Professor of Radiology Director of UCSD RECIST clinic Lecture Goals Origin of Lung Cancer Subtypes New Treatment Paradigms in Lung Cancer Overview of Lung Cancer Elizabeth Weihe, MD Assistant Professor of Radiology Director of UCSD RECIST clinic Lung (Bronchogenic)

More information

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology

Dr Rodney Itaki Lecturer Anatomical Pathology Discipline. University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology Neoplasia Dr Rodney Itaki Lecturer Anatomical Pathology Discipline University of Papua New Guinea School of Medicine & Health Sciences Division of Pathology General Considerations Overview: Neoplasia uncontrolled,

More information

Gastrointestinal pathology 2018 lecture 4. Dr Heyam Awad FRCPath

Gastrointestinal pathology 2018 lecture 4. Dr Heyam Awad FRCPath Gastrointestinal pathology 2018 lecture 4 Dr Heyam Awad FRCPath Topics to be covered Peptic ulcer disease Hiatal hernia Gastric neoplasms Peptic ulcer disease (PUD)= chronic gastric ulcer Causes H pylori

More information

Impact of immunostaining of pulmonary and mediastinal cytology

Impact of immunostaining of pulmonary and mediastinal cytology Impact of immunostaining of pulmonary and mediastinal cytology Harman Sekhon MD, PhD Director of Cytopathology Head of Ottawa-site Ontario Tumour Bank June 20, 2014 Disclaimer Pfizer: Honorarium-Advisory

More information

Chief Complain. For chemotherapy

Chief Complain. For chemotherapy Chief Complain For chemotherapy Present Illness 93.12 Progressive weakness of R t arm for 1 year X-ray: peneative lesion over right proximal humorous Bone scan: multiple increased intake Biopsy of distal

More information

Lung Tumor Cases: Common Problems and Helpful Hints

Lung Tumor Cases: Common Problems and Helpful Hints Lung Tumor Cases: Common Problems and Helpful Hints Brandon T. Larsen, MD, PhD Senior Associate Consultant Department of Laboratory Medicine and Pathology Mayo Clinic Arizona Arizona Society of Pathologists

More information

Note: The cause of testicular neoplasms remains unknown

Note: The cause of testicular neoplasms remains unknown - In the 15- to 34-year-old age group, they are the most common tumors of men. - Tumors of the testis are a heterogeneous group of neoplasms that include: I. Germ cell tumors : 95%; all are malignant.

More information

Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010

Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010 LSU HEALTH SCIENCES CENTER NSCLC Guidelines Feist-Weiller Cancer Center Molly Boyd, MD Glenn Mills, MD Syed Jafri, MD 1/1/2010 Initial Evaluation/Intervention: 1. Pathology Review 2. History and Physical

More information

Diagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD. November 18, 2017

Diagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD. November 18, 2017 Diagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD November 18, 2017 Disclosures I do not have a financial interest/arrangement or affiliation with one or more organizations

More information

Slide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology

Slide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology Slide 1 Investigation and management of lung cancer Robert Rintoul Department of Thoracic Oncology Papworth Hospital Slide 2 Epidemiology Second most common cancer in the UK (after breast). 38 000 new

More information

Pulmonary Nodules & Masses

Pulmonary Nodules & Masses Pulmonary Nodules & Masses A Diagnostic Approach Heber MacMahon The University of Chicago Department of Radiology Disclosure Information Consultant for Riverain Technology Minor equity in Hologic Royalties

More information

A 64 y.o. man presents to the hospital with persistent cough and hemoptysis. Fernando Mut Montevideo - Uruguay

A 64 y.o. man presents to the hospital with persistent cough and hemoptysis. Fernando Mut Montevideo - Uruguay A 64 y.o. man presents to the hospital with persistent cough and hemoptysis Fernando Mut Montevideo - Uruguay Teaching case Bone # 1 A 64 y.o. man presents to the hospital with persistent cough and hemoptysis.

More information

Lung /1/16. Please submit all questions concerning webinar content through the Q&A panel. Reminder:

Lung /1/16. Please submit all questions concerning webinar content through the Q&A panel. Reminder: 1 NAACCR 2015-2016 Webinar Series Collecting Cancer Data: Lung NAACCR 2015 2016 Webinar Series Presented by: Angela Martin amartin@naaccr.org Jim Hofferkamp jhofferkamp@naaccr.org Q&A Please submit all

More information

ONCOLOGY. Csaba Bödör. Department of Pathology and Experimental Cancer Research november 19., ÁOK, III.

ONCOLOGY. Csaba Bödör. Department of Pathology and Experimental Cancer Research november 19., ÁOK, III. ONCOLOGY Csaba Bödör Department of Pathology and Experimental Cancer Research 2018. november 19., ÁOK, III. bodor.csaba1@med.semmelweis-univ.hu ONCOLOGY Characteristics of Benign and Malignant Neoplasms

More information

Master Class: Fundamentals of Lung Cancer

Master Class: Fundamentals of Lung Cancer This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

INDEX. surgpath.theclinics.com. Note: Page numbers of article titles are in boldface type. diffuse pleural fibrosis, pleural plaques,

INDEX. surgpath.theclinics.com. Note: Page numbers of article titles are in boldface type. diffuse pleural fibrosis, pleural plaques, INDEX Note: Page numbers of article titles are in boldface type. A Adenocarcinoma, minimally invasive. See Minimally invasive adenocarcinoma (MIA). Airway-centered interstitial fibrosis, 183 184 ALK (anaplastic

More information

Salivary Glands 3/7/2017

Salivary Glands 3/7/2017 Salivary Glands 3/7/2017 Goals and objectives Focus on the entities unique to H&N Common board type facts Information for your future practice Salivary Glands Salivary Glands Major gland. Paratid. Submandibular.

More information

The Respiratory System

The Respiratory System The Respiratory System Respiratory Anatomy Upper respiratory tract Nose Nasal passages Pharynx Larynx Respiratory Anatomy Functions of the upper respiratory tract: Provide entry for inhaled air Respiratory

More information

Histopathological and CT Imaging Correlation of Various Primary Lung Carcinoma

Histopathological and CT Imaging Correlation of Various Primary Lung Carcinoma IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 3 Ver. VII (Mar. 2016), PP 104-110 www.iosrjournals.org Histopathological and CT Imaging Correlation

More information

Renal tumors of adults

Renal tumors of adults Renal tumors of adults Urinary Tract Tumors 2%-3% of all cancers in adults. The most common malignant tumor of the kidney is renal cell carcinoma. Tumors of the lower urinary tract are twice as common

More information

Epithelial tumors. Dr. F.F. Khuzin, PhD Dr. M.O. Mavlikeev

Epithelial tumors. Dr. F.F. Khuzin, PhD Dr. M.O. Mavlikeev Epithelial tumors Dr. F.F. Khuzin, PhD Dr. M.O. Mavlikeev Epithelial tumors Tumors from the epithelium are the most frequent among tumors. There are 2 group features of these tumors: The presence in most

More information

Presentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98

Presentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98 Presentation material is for education purposes only. All rights reserved. 2011 URMC Radiology Page 1 of 98 Radiology / Pathology Conference February 2011 Brooke Koltz, Cytopathology Resident Presentation

More information

Collecting Cancer Data: Lung

Collecting Cancer Data: Lung Collecting Cancer Data: Lung NAACCR 2011 2012 Webinar Series 2/2/2012 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this

More information

Lung Cancer - Suspected

Lung Cancer - Suspected Lung Cancer - Suspected Shared Decision Making Lung Cancer: http://www.enhertsccg.nhs.uk/ Patient presents with abnormal CXR Lung cancer - clinical presentation History and Examination Incidental finding

More information

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University To determine the regions of physiologic activity To understand

More information

The 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach

The 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach The 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach Dr. Carol Farver Director, Pulmonary Pathology Pathology and Laboratory Medicine Institute Objectives Discuss

More information

Respiratory Cytology and Ancillary diagnostic techniques. Dr Alex Rice Royal Brompton Hospital

Respiratory Cytology and Ancillary diagnostic techniques. Dr Alex Rice Royal Brompton Hospital Respiratory Cytology and Ancillary diagnostic techniques Dr Alex Rice Royal Brompton Hospital Overview Specialist Cardiothoracic centre BAL specimens and cell differential counts EBUS Diagnostic pitfalls

More information

Disclosures. Parathyroid Pathology. Objectives. The normal parathyroid 11/10/2012

Disclosures. Parathyroid Pathology. Objectives. The normal parathyroid 11/10/2012 Disclosures Parathyroid Pathology I have nothing to disclose Annemieke van Zante MD/PhD Assistant Professor of Clinical Pathology Associate Chief of Cytopathology Objectives 1. Review the pathologic features

More information

International Society of Gynecological Pathologists Symposium 2007

International Society of Gynecological Pathologists Symposium 2007 International Society of Gynecological Pathologists Symposium 2007 Anais Malpica, M.D. Department of Pathology The University of Texas M.D. Anderson Cancer Center Grading of Ovarian Cancer Histologic grade

More information

*according to content of fluid we can divide pleural effusion to 2 main types

*according to content of fluid we can divide pleural effusion to 2 main types Pleural lesion and lesion of the Done by: Upper respiratory tract Saef Bassam ma'adat **Lets start with pleural lesion there is a little differet between pleural effustion and empyema accumulation of fluid

More information

Charles Mulligan, MD, FACS, FCCP 26 March 2015

Charles Mulligan, MD, FACS, FCCP 26 March 2015 Charles Mulligan, MD, FACS, FCCP 26 March 2015 Review lung cancer statistics Review the risk factors Discuss presentation and staging Discuss treatment options and outcomes Discuss the status of screening

More information

Neoplasia part I. Dr. Mohsen Dashti. Clinical Medicine & Pathology nd Lecture

Neoplasia part I. Dr. Mohsen Dashti. Clinical Medicine & Pathology nd Lecture Neoplasia part I By Dr. Mohsen Dashti Clinical Medicine & Pathology 316 2 nd Lecture Lecture outline Review of structure & function. Basic definitions. Classification of neoplasms. Morphologic features.

More information

Neoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath

Neoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath Neoplasia 2018 Lecture 2 Dr Heyam Awad MD, FRCPath ILOS 1. List the differences between benign and malignant tumors. 2. Recognize the histological features of malignancy. 3. Define dysplasia and understand

More information

Pulmonary Neoplasm. Howard J. Sachs, MD

Pulmonary Neoplasm. Howard J. Sachs, MD Pulmonary Neoplasm Howard J. Sachs, MD www.12daysinmarch.com Adenocarcinoma (Most Common 50%) Large Cell Non-Small Cell Lung Cancers Squamous Cell Small Cell Adenocarcinoma Large Cell Dx of Exclusion Undifferentiated

More information

NEOPLASIA. 3. Which of the following tumour is benign a. Chondrosarcoma b. Osteochondroma c. Chondroblastoma d. Ewing s tumour e.

NEOPLASIA. 3. Which of the following tumour is benign a. Chondrosarcoma b. Osteochondroma c. Chondroblastoma d. Ewing s tumour e. NEOPLASIA 1. malignant neoplasms a. are independent of hormonal influence b. are always composed of homogenous cell lines c. arise from differentiated cells by a process of anaplasia d. display abnormal

More information

Tumors of kidney and urinary bladder

Tumors of kidney and urinary bladder Tumors of kidney and urinary bladder Overview of kidney tumors Benign and malignant Of the benign: papillary adenoma -cortical -small (0.5cm) -in 40% of population -clinically insignificant The most common

More information

Neoplasias Quisticas del Páncreas

Neoplasias Quisticas del Páncreas SEAP -Aproximación Práctica a la Patología Gastrointestinal- Madrid, 26 de mayo, 2006 Neoplasias Quisticas del Páncreas Gregory Y. Lauwers, M.D. Director, Service Massachusetts General Hospital Harvard

More information

Advancing Health Equity in Lung Cancer Outcomes

Advancing Health Equity in Lung Cancer Outcomes Advancing Health Equity in Lung Cancer Outcomes Edwin J Jackson Jr. DO Pulmonary and Critical Care Medicine Disclosures Funding: American Thoracic Society 2 1 Lecture Outline Cancer Disparities Smoking

More information

What is New in the 2015 WHO Lung Cancer Classification? Zhaolin Xu, MD, FRCPC, FCAP

What is New in the 2015 WHO Lung Cancer Classification? Zhaolin Xu, MD, FRCPC, FCAP What is New in the 2015 WHO Lung Cancer Classification? Zhaolin Xu, MD, FRCPC, FCAP Professor, Dept of Pathology, Dalhousie University, Canada Pulmonary Pathologist and Cytopathologist, QEII HSC Senior

More information

Renal Parenchymal Neoplasms

Renal Parenchymal Neoplasms Renal Parenchymal Neoplasms د. BENIGN TUMORS : Benign renal tumors include adenoma, oncocytoma, angiomyolipoma, leiomyoma, lipoma, hemangioma, and juxtaglomerular tumors. Renal Adenomas : The adenoma is

More information

Histology: Its Influence on Therapeutic Decision Making

Histology: Its Influence on Therapeutic Decision Making Histology: Its Influence on Therapeutic Decision Making Mark A. Socinski, MD Professor of Medicine and Thoracic Surgery Director, Lung Cancer Section, Division of Hematology/Oncology Co-Director, UPMC

More information

Pathology of Mediastinal Tumors

Pathology of Mediastinal Tumors SAMO Meeting Lucerne 2009 Pathology of Mediastinal Tumors Alex Soltermann Most common lesions (adults) Clinical presentation 50% of the patients are asymptomatic, lesion discovered incidentally Symptoms

More information

Lung Cancer Diagnosis for Primary Care

Lung Cancer Diagnosis for Primary Care Lung Cancer Diagnosis for Primary Care Daniel Nader, DO, FCCP Cancer Treatment Center of America Case 1 In which of the following situations would the U.S. Preventive Services Task Force (USPSTF) recommend

More information

The Pathology of GATRA/GCCR FALL CONFERENCE NOVEMBER 14-16, /6/2012. Lung Cancer Epidemiology. Dean W. Joelson, M.D.

The Pathology of GATRA/GCCR FALL CONFERENCE NOVEMBER 14-16, /6/2012. Lung Cancer Epidemiology. Dean W. Joelson, M.D. The Pathology of Lung and Colon oo Cancer Dean W. Joelson, M.D. Lung Cancer Epidemiology Risk Factors: Smoking Smoking Second-hand smoke Other environmental exposures: Radon gas, asbestos, diesel exhaust,

More information

Slide 120, Lobar Pneumonia. Slide 120, Lobar Pneumonia. Slide 172, Interstitial Pneumonia. Slide 172, Interstitial Pneumonia. 53 Year-Old Smoker

Slide 120, Lobar Pneumonia. Slide 120, Lobar Pneumonia. Slide 172, Interstitial Pneumonia. Slide 172, Interstitial Pneumonia. 53 Year-Old Smoker Slide 120, Lobar Pneumonia Slide 120, Lobar Pneumonia Slide 172, Interstitial Pneumonia Slide 172, Interstitial Pneumonia 53 Year-Old Smoker Emphysema Pink puffer Barrel chest Hyperinflation Trapped air

More information

Medical Management of Non-Small Cell Lung Cancer

Medical Management of Non-Small Cell Lung Cancer Medical Management of Non-Small Cell Lung Cancer GS Bhattacharyya, D Sarkar Consultant Medical Oncologist and Clinical Haematologist, B.R. Singh Hospital, Eastern Railway & Institute of Pulmocare, Kolkata;

More information

Lung 8/7/14. Collecting Cancer Data: Lung NAACCR Webinar Series. August 7, 2014

Lung 8/7/14. Collecting Cancer Data: Lung NAACCR Webinar Series. August 7, 2014 Collecting Cancer Data: Lung 2013 2014 NAACCR Webinar Series August 7, 2014 Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching

More information

Case year old female presented with asymmetric enlargement of the left lobe of the thyroid

Case year old female presented with asymmetric enlargement of the left lobe of the thyroid Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.

More information

POORLY DIFFERENTIATED, HIGH GRADE AND ANAPLASTIC CARCINOMAS: WHAT IS EVERYONE TALKING ABOUT?

POORLY DIFFERENTIATED, HIGH GRADE AND ANAPLASTIC CARCINOMAS: WHAT IS EVERYONE TALKING ABOUT? POORLY DIFFERENTIATED, HIGH GRADE AND ANAPLASTIC CARCINOMAS: WHAT IS EVERYONE TALKING ABOUT? AGGRESSIVE THYROID CANCERS PAPILLARY CARCINOMA CERTAIN SUBTYPES POORLY DIFFERENTIATED CARCINOMA HIGH GRADE DIFFERENTIATED

More information

Case 4 Diagnosis 2/21/2011 TGB

Case 4 Diagnosis 2/21/2011 TGB Case 4 22 year old female presented with asymmetric enlargement of the left lobe of the thyroid gland. No information available relative to a prior fine needle aspiration biopsy. A left lobectomy was performed.

More information

Approach to Pulmonary Nodules

Approach to Pulmonary Nodules Approach to Pulmonary Nodules Edwin Jackson, Jr., DO Assistant Professor-Clinical Director, James Early Detection Clinic Department of Internal Medicine Division of Pulmonary, Allergy, Critical Care and

More information

PDF created with pdffactory Pro trial version

PDF created with pdffactory Pro trial version Neuroblastoma Tumor derived from neural crest cell that form the sympathetic ganglia&adrenal medulla. Causes *unknown. *familial neuroblastoma has been reported but is rare. * The incidence is 1:100,000

More information

-The cause of testicular neoplasms remains unknown

-The cause of testicular neoplasms remains unknown - In the 15- to 34-year-old age group, they are the most common tumors of men. - include: I. Germ cell tumors : (95%); all are malignant. II. Sex cord-stromal tumors: from Sertoli or Leydig cells; usually

More information

Non-Small Cell Lung Carcinoma - Myers

Non-Small Cell Lung Carcinoma - Myers Role of Routine Histology and Special Testing in Managing Patients with Non- Small Cell Lung Carcinoma Jeffrey L. Myers, M.D. A. James French Professor Director, Anatomic Pathology & MLabs University of

More information

Pitfalls in thyroid tumor pathology. Prof.Valdi Pešutić-Pisac MD, PhD

Pitfalls in thyroid tumor pathology. Prof.Valdi Pešutić-Pisac MD, PhD Pitfalls in thyroid tumor pathology Prof.Valdi Pešutić-Pisac MD, PhD Too many or... Tumour herniation through a torn capsule simulating capsular invasion fibrous capsule with a sharp discontinuity, suggestive

More information

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal

1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal Diseases of cervix I. Inflammations 1.Acute and Chronic Cervicitis - At the onset of menarche, the production of estrogens by the ovary stimulates maturation of the cervical and vaginal squamous mucosa

More information

Lung /4/18. Please submit all questions concerning the webinar content through the Q&A panel.

Lung /4/18. Please submit all questions concerning the webinar content through the Q&A panel. Lung NAACCR 2018 2019 WEBINAR SERIES 1 Q&A Please submit all questions concerning the webinar content through the Q&A panel. If you have participants watching this webinar at your site, please collect

More information